Skip to main content
. 2015 Apr 29;10(4):e0124889. doi: 10.1371/journal.pone.0124889

Fig 2. Overall Survival.

Fig 2

Kaplain-Meier overall survival (OS) curves comparing toceranib-treated dogs with control dogs. Hash marks denote censored observations; n = 63 toceranib-treated dogs; n = 63 control dogs (p = 0.08).